NCT01747135View on ClinicalTrials.gov

Hydroxypropyl Beta Cyclodextrin for Niemann-Pick Type C1 Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Niemann-Pick Disease, Type C1
Interventions
DRUG

VTS-270

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

Vtesse, LLC, a Mallinckrodt Pharmaceuticals Company

INDUSTRY

NCT01747135 - Hydroxypropyl Beta Cyclodextrin for Niemann-Pick Type C1 Disease | Biotech Hunter | Biotech Hunter